Recently presented live at the 2024 Society of Toxicology Meeting in Utah,
you can now access all of the webcasts anytime, and anywhere.
Join the journey with us by visiting
one of our bi-weekly industry Blogs
Advance™ technology-enabled solution enables R&D organizations to cut study timelines, deliver cost savings and reduce animal experimentation.
Healthcare investment specialist ARCHIMED has the expertise, experience, enthusiasm and financial strength to fully back Instem’s ambitions.
New Software Module Introduced to Support the Latest Regulatory-approved Carcinogenic Potency Categorization Approach (CPCA)
© 2024 Instem Group of Companies